Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
22 avr. 2024 07h51 HE
|
Stereotaxis, Inc.
Stereotaxis will host first-quarter financial results on May 13, 2024.
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
04 mars 2024 16h06 HE
|
Stereotaxis, Inc.
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis Reports 2023 Full Year Financial Results
04 mars 2024 16h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
22 févr. 2024 16h15 HE
|
Stereotaxis, Inc.
Intermountain Medical Center becomes the first hospital in the Intermountain region and in Utah to adopt the latest in robotic heart care technology.
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
20 févr. 2024 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter
08 janv. 2024 08h34 HE
|
Stereotaxis, Inc.
Stereotaxis announces first patients treated using new Magnetic Interventional Catheter, MAGiC
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
28 nov. 2023 08h42 HE
|
Stereotaxis, Inc.
Baptist Health Lexington has become one of the first in the world to provide the latest in robotic technology to treat arrhythmias
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference
20 nov. 2023 08h54 HE
|
Stereotaxis, Inc.
Stereotaxis Chairman and CEO, David Fischel, will again participate in the Piper Sandler Healthcare Conference.
Stereotaxis Reports 2023 Third Quarter Financial Results
09 nov. 2023 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States
31 oct. 2023 08h57 HE
|
Stereotaxis, Inc.
Stereotaxis (NYSE: STXS) & Abbott (NYSE:ABT) announce the first patients in the US have been treated successfully utilizing combined technologies